王安國 An-Guor Wang

Doctor Wang graduated from Taipei Medical University and completed his ophthalmic residency/fellowship at Taipei Veterans General Hospital. He also graduated from National Yang-Ming University as a PhD in neurobiology. Now he is the senior consultant in Taipei Veterans General Hospital, and associate professor at National Yang-Ming Chiao-Tung University. He serves as council member of Taiwan Ophthalmological Society, APAO and APSPOS. He is currently the secretary general of Asian Neuro-ophthalmology Society. He serves as the section editor of “Journal of Neuro-ophthalmology”, and as the associate editor of “Neuro-ophthalmology”. He also has authored a book “Emergency Neuro-ophthalmology”.

Day 1 Saturday - 13 Dec 2025

Time Session
08:30
12:00
EN
  • 林慧茹 Hui-Ju LinTaiwan Speaker Advances in Artificial Intelligence Models and Algorithms in Amblyopia and Strabismus Review of Artificial Intelligence (AI) models that detect strabismus and amblyopia risk factors from smartphone photos, videos, and images, facilitating large-scale, accessible community screening. Discussion on how AI is personalizing amblyopia therapy, thereby maximizing efficacy and engagement. Critical appraisal of the requirements for clinical validation, regulatory approval, and the ethical integration of these AI tools into standard ophthalmic practice. AI is poised to fundamentally reshape the management of strabismus and amblyopia by introducing unprecedented levels of objectivity, accessibility, and personalization. the knowledge to understand, evaluate, and eventually integrate these powerful technologies into their practice to improve patient outcomes. AI screening and diagnosis to treatment optimization and monitoring.
  • 林慧茹 Hui-Ju LinTaiwan Moderator Advances in Artificial Intelligence Models and Algorithms in Amblyopia and Strabismus Review of Artificial Intelligence (AI) models that detect strabismus and amblyopia risk factors from smartphone photos, videos, and images, facilitating large-scale, accessible community screening. Discussion on how AI is personalizing amblyopia therapy, thereby maximizing efficacy and engagement. Critical appraisal of the requirements for clinical validation, regulatory approval, and the ethical integration of these AI tools into standard ophthalmic practice. AI is poised to fundamentally reshape the management of strabismus and amblyopia by introducing unprecedented levels of objectivity, accessibility, and personalization. the knowledge to understand, evaluate, and eventually integrate these powerful technologies into their practice to improve patient outcomes. AI screening and diagnosis to treatment optimization and monitoring.
  • 陳南妮 Nan-Ni ChenTaiwan Speaker Prepared and Ready for Your First Refractive SurgeryEvidence-based recommendations for KLEx in clinical practice -preoperative screening for keratoconus -surgical planning -management and prevention of complications and infection.
  • Hyun Jin ShinKorea (Republic of) Speaker Emergence Point of the Infratrochlear Nerve With Reference to the Nasion and Its Clinical Implications in Craniofacial SurgeryAbstract Infratrochlear nerve (ITN) block is widely utilized for achieving surgical anesthesia, reducing postoperative pain, and treating neuralgia. The aim of this study was to identify the emerging point of the ITN (EP-ITN) in the medial orbital margin with reference to the nasion in order to enhance the effectiveness of regional ITN block in craniofacial surgery. Thirty-eight hemifaces from 19 embalmed Korean cadavers were dissected. Measurements were made of the vertical distances from the EP-ITN to key landmarks such as the nasion, the inferior border of the trochlea, and the medial canthus. The study also analyzed facial morphology by measuring the horizontal and vertical dimensions of the midface and orbit. The spatial relationships between these landmarks and the EP-ITN relative to the dimensions of the midface and orbit were also evaluated. The distances from the EP-ITN to the nasion, trochlea, and medial canthus were 1.6±1.3 mm (mean±standard deviation), 19.7±1.7 mm, and 11.7±2.0 mm, respectively. The distance between the trochlea and the EP-ITN also tended to increase as the horizontal dimensions of the midface and orbit increased. However, the dimensions of the midface and orbit did not significantly affect the distance from the nasion to the EP-ITN. In conclusion, the nasion is located nearer to the EP-ITN than to other landmarks and maintains a consistent spatial relationship that is unaffected by variations in the size of the midface or orbit. This means that it can serve as a reliable external landmark for guiding the ITN block technique.
  • Sun Woong KimKorea (Republic of) Speaker Mouse Meibomian Gland Progenitor Cell Organoids as an In Vitro Model of Acinar and Ductal DifferentiationPurpose: Recent studies have shown that two-dimensional (2D) culture of primary rabbit and immortalized human meibomian gland epithelial cells (iHMGEC) do not recapitulate normal meibocyte differentiation, but 3D-spheroid culture of iHMGEC can facilitate meibocyte differentiation. The purpose of this study was to develop mouse meibomian gland (MG) organoid which can be capable of differentiating to MG acini and duct. Methods: Mouse meibomian gland epithelial cells were isolated and were suspended in matrigel/basement membrane matrix and grown in proliferation media supplemented with Rock inhibitor (Y-27632), Noggin, A8301, FGF10, and Rspondin1 to form adult progenitor cell clusters or spheroids. Cells were then differentiated with serum-free, differentiation media with or without synthetic agonists for the nuclear lipid receptor, peroxisome proliferator activator receptor gamma (PPARγ). Cells were then evaluated for differentiation markers using western blotting, immunocytochemistry (ICC) and real-time PCR. Results: The 3D culture induced the formation of KRT5+ spheroids that were enriched with Lrig1+, Sox9+, and Lgr6+ cells at the outer layer. These MG progenitor cell organoids can be passaged more than 30 times and were still capable of developing MG-like phenotypes as indicated by lipid synthesis as well as expression of essential proteins related to meibum synthesis. When MG progenitor cell organoids were switched to differentiation media containing PPARγ agonists, accumulation of lipid droplets and cell death were observed in the center of organoids, which demonstrates that these progenitor cell organoids can differentiate and response to differentiation signals. Meibocyte differentiation marker, AWAT2+/PPARγ+ were expressed in acini-like organoid and KRT6a+ duct like organoids were also formed. Some organoids showed both duct and acini phenotypes. Conclusions: The 3D culturing of mouse MG progenitor cells can induce the formation of both acini and ductal organoids and may thus serve as a better in vitro model system for studying the regulatory mechanisms controlling meibomian gland function. Mimicking MG homeostasis, the outer layer of MG organoids is composed of proliferating cells that migrate inward, undergo terminal differentiation and generating lipid-filled meibocytes.
  • 王安國 An-Guor WangTaiwan Moderator Upshooting Eye After TED IR Myectomy: How Do We Manage? Two TED patients received IR myectomy for hypotropoia. They developed upshooting eyes with severe limitation of infraduction postoperatively. We collaborated with ENT surgeon using endoscopic surgery with navigation system to identify the proximal stump of IR, and repair with non-absorbable suture. Both patients recovered their binocular vision after the operation.
  • Min Chae KangKorea (Republic of) Speaker Monitoring Changes in Optic Nerve Thickness Using OCT in Patients with Pseudopapilledema Associated with Peripapillary Hyperreflective Ovoid Mass-like Structures (PHOMS)This study investigated longitudinal changes in optic nerve thickness using spectral-domain optical coherence tomography (SD-OCT) in patients with pseudopapilledema associated with peripapillary hyperreflective ovoid mass-like structures (PHOMS). Ninety-two eyes from 48 patients were evaluated, and peripapillary retinal nerve fiber layer (pRNFL) thickness was measured in five sectors (average, superior, inferior, temporal, and nasal) for up to 24 months. Eyes were classified as either “with increase in pRNFL thickness” or “without increase,” based on an average pRNFL increase of ≥5 μm compared with the previous measurement and a monthly rate of ≥10 μm. Sixty-four eyes showed no increase, while 28 demonstrated thickening. Age, sex, refractive error, and time to maximal thickening did not differ significantly between groups. The group with thickness increase had greater average (116.95 ± 29.41 vs. 106.87 ± 19.02, p = 0.034) and inferior (161.18 ± 60.12 vs. 136.63 ± 28.01, p = 0.034) sectoral values. Changes from the previous measurement were larger in this group for the average (0.81 ± 16.02 vs. −3.43 ± 12.50, p = 0.029) and inferior (4.73 ± 35.08 vs. −5.10 ± 16.11, p = 0.013) sectors, with the inferior sector showing the greatest change (p = 0.037). The monthly rate of change was also higher across several sectors in eyes with increased thickness. These results suggest that PHOMS-related pseudopapilledema demonstrates dynamic optic nerve morphology, and that inferior sector pRNFL fluctuations on OCT may serve as a useful indicator of optic nerve changes in these patients.
  • Yun Jeong LeeSouth Korea Speaker Deep Learning for Differentiating Glaucomatous and Non-glaucomatous Optic Neuropathy with Retinal Nerve Fiber Layer and Optic Disc PhotographsPurpose: To develop a deep learning (DL)-based algorithm to differentiate glaucomatous optic neuropathy (GON) and non-glaucomatous optic neuropathy (NGON) with retinal nerve fiber layer (RNFL) and optic disc photographs. Methods: A total of 765 image pairs (618 GON, 147 NGON) were retrospectively collected and preprocessed using histogram matching and region-of-interest cropping based on Hough circle detection. An external validation dataset consisting of 177 pairs (103 GON, 74 NGON) was also used. DL models were developed using ResNet34 for optic disc images and DenseNet121 for RNFL images, with feature-level fusion implemented via cross-attention mechanisms. Model training involved data augmentation, class imbalance correction, and five-fold cross-validation. Model interpretability was assessed using Grad-CAM visualization. Results: The proposed model demonstrated robust performance in both internal and external datasets. In the internal validation set, the DL model achieved an AUC of 0.98 with the RNFL images, which was comparable to that with the optic disc (AUC of 0.99, P = 0.23) or combined RNFL and optic disc images (AUC of 0.98, P = 0.70), and was significantly superior to that with the masked RNFL (AUC of 0.94, P < 0.05) or combined masked RNFL and optic disc images (AUC of 0.96, P < 0.05). In the external validation set, the fusion model integrating both RNFL and optic disc images achieved superior diagnostic performance compared to single-modality models, with the highest AUC (0.88). Conclusions: The proposed multi-input DL model effectively differentiates between GON and NGON using RNFL and optic disc photographs. By integrating structural features via cross-attention, the model achieves consistent diagnostic performance, even in external datasets. This suggests the potential value of our DL model in clinical practice by helping clinicians make accurate diagnoses and treatment decisions.
  • 陳達慶 Ta-Ching ChenTaiwan Moderator Hidden Variants in Inherited Retinal Degeneration and Their Impact on Gene-Targeted TreatmentIn this short talk, we would like to share the experience about systematically identifying pathogenic splicing variants and characterizing their transcript-level consequences to enhance the the molecular diagnosis of inherited retinal degeneration (IRD). In 738 IRD families, a splicing variant detection pipeline, integrating two computational algorithms (SpliceAI and dbscSNV_ADA) with functional validation via minigene assays, was implemented to detect splice-disrupting variants beyond canonical sites. Splicing variants accounted for 14% of genetically diagnosed families. Of these, 4% were newly identified through our combined computational and experimental platform. Notably, 28% of all splice-disrupting variants, located in noncanonical, exonic, or deep-intronic regions, would likely have been missed by conventional analysis pipelines, which typically prioritize protein-coding changes and canonical splice sites, and often lack systematic evaluation of splicing effects beyond these regions. Five recurrent splice-disrupting variants were observed across multiple families, including EYS:c.5644+5G>A, which caused exon truncation and was found in 11 unrelated families. Functional assays confirmed aberrant splicing, and the associated phenotypes were consistent with known disease presentations. This study demonstrates the utility of a combined splicing variant detection platform in uncovering hidden pathogenic variants and improving IRD diagnostic yield. These findings have implications for refining genetic testing and guiding the development of splicing-targeted therapies.
  • Sung who ParkKorea (Republic of) Speaker Pseudophakic Cystoid Macular Edema (PCME): The Central Role of Lens Removal and Anterior Uveal RemodelingBackground: PCME, commonly manifesting 4 to 12 weeks following cataract surgery, is characterized by increased vascular permeability. While its high responsiveness to topical NSAIDs suggests prostaglandin involvement, key paradoxes remain: Why is PCME frequently induced by the relatively simple cataract procedure, yet rarely follows more invasive surgeries like vitrectomy or trabeculectomy? And how do topical NSAIDs achieve therapeutic efficacy at the macula despite anatomical barriers such as the cornea and continuous aqueous flow? Hypothesis and Methods: We hypothesize that the pathological trigger is not generalized surgical trauma, but the structural changes caused by crystalline lens removal. The replacement of the large, heavy crystal lens with a small, lightweight intraocular lens necessitates adaptive remodeling of the anterior uvea. We propose that this remodeling results in prostaglandin release from this key pathological structure. To verify this, we conducted two studies analyzing PCME incidence after vitrectomy alone versus phacovitrectomy. Results: Our findings demonstrated that PCME incidence is significantly higher following phacovitrectomy compared to vitrectomy alone, strongly implicating lens removal as the main trigger for the syndrome. Furthermore, PCME was effectively reduced by topical NSAID administration after phacovitrectomy but was not significantly affected by the same treatment following vitrectomy alone. Conclusion: PCME pathogenesis is redefined by circumstances changes induced by crystalline lens removal, leading to prostaglandin release mediated by the anterior uvea. This novel model challenges the traditional view that PCME is solely a consequence of non-specific surgical inflammation, offering a precise anatomical target for both research and prophylaxis.
701F
14:30
17:30
EN
  • 林昭文 Chao-Wen LinTaiwan Speaker Neuroprotective Effects of Novel Treatments on Optic NeuritisOptic neuritis can cause visual impairment through retinal nerve fiber layer (RNFL) degeneration. Optical coherence tomography (OCT) could serve as a sensitive noninvasive tool for measuring RNFL thickness and evaluating the neuroprotective effects of treatment. In this topic, we reported a meta-analysis to compare RNFL loss between novel add-on treatments and traditional corticosteroid therapy after acute optic neuritis. The outcome measures were mean differences in (1) RNFL thickness compared with the baseline in the affected and unaffected eye and (2) LogMAR visual acuity (VA). Seven studies involving five novel agents (memantine, erythropoietin, interferon-beta, phenytoin, and clemastine) were included.
  • 蔡榮坤 Rong-Kung TsaiTaiwan Speaker Current Potential Neuroprotectants on Optic NeuropathiesHuman optic nerve can not regenerate after optic nerve damage. Current treatments of optic neuropathies are limited by using steroids and supportive treatments. After optic nerve injury, the primary insult affect the optic nerve function immediately, the secondly damage occurs by barrier shotdown and inflammation and results in RGCs apoptosis around one to two weeks. Therefore, there may exist some neuroprotectants to prevent the second insults to protect RGCs in the therapeutic window. For optic atrophy from all causes, cell-replacement therapies may serve as an emerging regenerative medicine in the future. Several preclinical reports and clinical trials have shown some promising results in neuroprotection and neuro-regeneration. This talk will discuss some potential neuroprotectants and neuro-regeneration in current era, as well as the challenges to conduct clinical trials.
  • Satoshi KashiiJapan Speaker Why do we roll our eyes? The fundamentals of vision—light perception, visual acuity, and the visual field—are perceived by the brain through complex logarithmic transformations of external stimuli. This mathematical operation is performed by the axonal projections of neurons from the retina through the optic nerve to the visual cortex (V1). The complex coordinate transformations are actually the result of intermolecular forces. However, vision is not simply a static perception of images on the retina. Through the oculomotor system, the brain dynamically and predictively captures objects, reconstructing the external world within the brain while reproducing visual images. Without moving the eyes, it is impossible to perceive depth. For example, fixating on the center of a slanted pencil, cover your right eye. You will immediately notice the upper end tilted temporally. Covering the left eye induces an outward (temporal) tilt of the upper end. The perceived images of a vertical object in each eye are extorted. Here, we roll our eyes to optimize the cyclodisparity stimulus for stereoscopic depth perception in the pitch plane—that is, to see things in 3D: length, width, and “depth”. But that’s not all. Vergence eye movements are not essential for stereoscopic depth perception. We do not need to roll our eyes to see things in 3D once we have learned and developed binocular vision during the critical period of visual system development. The key to 3D vision lies in neurodevelopment during infancy.
  • 孫銘輝 Ming-Hui SunTaiwan Speaker Eye movement disorders in neurodegenerative diseasesEye movement includes saccade, pursuit, and vergence. Abnormal eye movement or accuracy and speed of saccade was common in patients with neurodegeneration diseases such as Parkinson disease. Recording eye movement by using eye tracker has a diagnostic value in differentiating between these disorders and also help the existence of underlying common pathological mechanisms.
  • Umapathi N.ThirugnanamSingapore Speaker Do Not fear Nystagmus!Using a series of clinical cases, I would illustrate a mechanistic approach to understanding the different types of nystagmus and their clinical significance.
  • 鄭惠禎 Hui-Chen ChengTaiwan Speaker Clinical Management of NystagmusNystagmus is characterized by involuntary, rapid, and repetitive eye movements that can substantially affect visual function and quality of life. Its clinical management requires a comprehensive, multidisciplinary approach that may include optical correction, pharmacologic therapy, and, in selected cases, surgical procedures to modify extraocular muscle positioning. This presentation aims to summarize the current evidence and practical strategies for managing nystagmus in daily clinical practice.
  • 蔡榮坤 Rong-Kung TsaiTaiwan Moderator Current Potential Neuroprotectants on Optic NeuropathiesHuman optic nerve can not regenerate after optic nerve damage. Current treatments of optic neuropathies are limited by using steroids and supportive treatments. After optic nerve injury, the primary insult affect the optic nerve function immediately, the secondly damage occurs by barrier shotdown and inflammation and results in RGCs apoptosis around one to two weeks. Therefore, there may exist some neuroprotectants to prevent the second insults to protect RGCs in the therapeutic window. For optic atrophy from all causes, cell-replacement therapies may serve as an emerging regenerative medicine in the future. Several preclinical reports and clinical trials have shown some promising results in neuroprotection and neuro-regeneration. This talk will discuss some potential neuroprotectants and neuro-regeneration in current era, as well as the challenges to conduct clinical trials.
    王安國 An-Guor WangTaiwan Moderator Upshooting Eye After TED IR Myectomy: How Do We Manage? Two TED patients received IR myectomy for hypotropoia. They developed upshooting eyes with severe limitation of infraduction postoperatively. We collaborated with ENT surgeon using endoscopic surgery with navigation system to identify the proximal stump of IR, and repair with non-absorbable suture. Both patients recovered their binocular vision after the operation.
    鄭惠禎 Hui-Chen ChengTaiwan Discussant Clinical Management of NystagmusNystagmus is characterized by involuntary, rapid, and repetitive eye movements that can substantially affect visual function and quality of life. Its clinical management requires a comprehensive, multidisciplinary approach that may include optical correction, pharmacologic therapy, and, in selected cases, surgical procedures to modify extraocular muscle positioning. This presentation aims to summarize the current evidence and practical strategies for managing nystagmus in daily clinical practice.
    林昭文 Chao-Wen LinTaiwan Discussant Neuroprotective Effects of Novel Treatments on Optic NeuritisOptic neuritis can cause visual impairment through retinal nerve fiber layer (RNFL) degeneration. Optical coherence tomography (OCT) could serve as a sensitive noninvasive tool for measuring RNFL thickness and evaluating the neuroprotective effects of treatment. In this topic, we reported a meta-analysis to compare RNFL loss between novel add-on treatments and traditional corticosteroid therapy after acute optic neuritis. The outcome measures were mean differences in (1) RNFL thickness compared with the baseline in the affected and unaffected eye and (2) LogMAR visual acuity (VA). Seven studies involving five novel agents (memantine, erythropoietin, interferon-beta, phenytoin, and clemastine) were included.
  • 孫雯軒 Wen-Hsuan SunTaiwan Speaker A Case of Sudden Vision Loss After Cardiac SurgeryA 52-year-old woman with Marfan syndrome and a long-standing history of complex aortic disease presented with sudden blurred vision in her right eye one day after undergoing major cardiovascular surgery. She previously received a Bentall procedure with a mechanical aortic valve and had multiple episodes of progressive aortic dissection requiring repeated arch grafting and endovascular repair. Over the past several months, she had been followed by cardiovascular surgery for dizziness, nausea, intermittent visual disturbance, and episodic chest and back discomfort. Her medical history also included hypertension and chronic anticoagulation, with recent laboratory tests showing elevated PT and INR. After her most recent operation for thoracoabdominal aortic pathology, she noted acute painless visual decline. Her best-corrected visual acuity was 0.05 in the right eye and 0.5 in the left, with a right relative afferent pupillary defect. The intraocular pressure showed 8 mmHg in the right eye and 10 mmHg in the left eye. Fundus examination revealed only subtle optic pallor without disc edema or cherry-red spot. Further image studies were arranged.
  • 林韋寧 Wei-Ning LinTaiwan Speaker Challenge CaseA challenge case will be presented.離開與回歸:我在不同醫療場域中找到的眼科價值離開醫學中心到基層,三年後又再回到醫中就職,職涯中的轉折,是機運與選擇共同譜寫出的有趣故事。
  • 林德蘭 De-Lan LinTaiwan Speaker Bilateral blurred vision for two monthsA 66-year-old man presented with a two-month history of bilateral blurred vision. He reported difficulty seeing objects, including an inability to clearly identify vehicle license plates, along with diminished image clarity while watching television. These symptoms persisted without any improvement over the entire two-months.
701G

Day 2 Sunday - 14 Dec 2025

Time Session
08:20
12:00
EN
  • 林慧茹 Hui-Ju LinTaiwan Moderator Advances in Artificial Intelligence Models and Algorithms in Amblyopia and Strabismus Review of Artificial Intelligence (AI) models that detect strabismus and amblyopia risk factors from smartphone photos, videos, and images, facilitating large-scale, accessible community screening. Discussion on how AI is personalizing amblyopia therapy, thereby maximizing efficacy and engagement. Critical appraisal of the requirements for clinical validation, regulatory approval, and the ethical integration of these AI tools into standard ophthalmic practice. AI is poised to fundamentally reshape the management of strabismus and amblyopia by introducing unprecedented levels of objectivity, accessibility, and personalization. the knowledge to understand, evaluate, and eventually integrate these powerful technologies into their practice to improve patient outcomes. AI screening and diagnosis to treatment optimization and monitoring.
  • 蔡忠斌 Chong-Bin TsaiTaiwan Speaker Could Botulinum Toxin Be an Effective Primary Treatment for Infantile Esotropia?Introduction: To report the long-term success rate of botulinum toxin as the primary treatment for infantile esotropia. Methods: A single-center, retrospective review examined botulinum toxin use in children with esotropia onset before 12 months and presented by age 48 months. Success was defined as ocular alignment within 10 prism diopters (PD) of orthotropia. Results: A total of 35 children received botulinum toxin as primary treatment (1 injection: 63%; 2 injections: 17%; 3 injections: 14%; 4 injections: 6%). Of these, 20 (57%) had only botulinum toxin (BT group), while 15 (43%) had both botulinum toxin and surgery (BT+OP group). The mean deviation at initial presentation was 46.5 ± 13.8 PD in the BT group and 47.3 ± 11.3 PD in the BT+OP group. The mean age for initial botulinum toxin treatment was 1.8 ± 0.8 years for the BT group and 1.5 ± 0.8 years for the BT+OP group. The average follow-up time was 37.3 ± 22.6 months for the entire group. The success rate was 75% (15 of 20) for the BT group and 53% (8 of 15) for the BT+OP group, with no significant difference in success rates between the groups. Conclusions: Botulinum toxin demonstrated a notable long-term success rate as a primary treatment for infantile esotropia. These findings suggest botulinum toxin is an effective initial treatment option, with sustained results observed over an average follow-up of over three years.
  • 王安國 An-Guor WangTaiwan Speaker Upshooting Eye After TED IR Myectomy: How Do We Manage? Two TED patients received IR myectomy for hypotropoia. They developed upshooting eyes with severe limitation of infraduction postoperatively. We collaborated with ENT surgeon using endoscopic surgery with navigation system to identify the proximal stump of IR, and repair with non-absorbable suture. Both patients recovered their binocular vision after the operation.
  • Zia ChaudhuriIndia Speaker High-Resolution Orbital MRI in strabismus and myopia: A Fascinating Journey of DiscoveryMagnetic resonance imaging (MRI) provides in vivo visualization of the static and dynamic configuration of extraocular muscles (EOM) and their connective tissues, aiding delineation of their anatomy and physiological functions. Defining the normal is of relevance because it aids extrapolation of the abnormal, which has translational relevance for the appropriate diagnosis and management of strabismus. This evaluation has also been found to be of high informative relevance in myopia, which has assumed pandemic stature in the east Asian population and now, also in the south Asian population. In addition, high-resolution surface coil orbital MRI techniques with suitable positioning of the eyeballs in different target-controlled positions aids knowledge of the actions of EOMs in different positions of conjugate gaze, as well as during convergence at near. Dr Chaudhuri was trained in the acquisition and analysis of these high-resolution orbital images in strabismus under the direct supervision of Prof Joseph Demer at JSEI, UCLA and has subsequently continued this research in India, thus making her an investigator from both sides of the ocean, so to say, and in different ethnic populations. This presentation will specifically provide an overview of high-resolution, surface-coil orbital MRI of the EOMs and ocular adnexa with due emphasis on congenital and acquired strabismus and myopia, including the enigmatic condition of myopic anisometropia, where despite similar genetics and environment, the two eyes grow asymmetrically.
  • Stephen KraftCanada Speaker Adult Strabismus Surgery: Do Adjustable Sutures Increase the Success of Surgery?Studies comparing strabismus surgical cases using adjustable sutures (AS) to non-adjustable procedures (NA) have focused on the rate of re-operations as well as the alignment results. The majority of the articles, encompassing hundreds of patients, show that AS improve success from both the reoperation rate and alignment aspects. However, systematic reviews point out that prospective controlled studies are lacking, and so conclusions cannot be drawn about the effectiveness of AS. This presentation will provide a brief review of the main articles in the literature comparing success rates with AS versus NA cases, as well as the five goals of an eye muscle operation. Following this introduction, the talk will illustrate the technique the author uses for his AS. Finally, the author will present three lines of evidence confirming the improved alignment success of using AS versus NA cases. This evidence derives from his over 40 years of experience and which is published in several articles from his centre. It is hoped that after this presentation, both novice and experienced strabismus surgeons will feel comfortable incorporating AS into their cases. They will also understand that the additional time and effort in using AS will be justified in improving the success rate of their surgery.Pearls and Tips from 43 Years in StrabismologyIn addition to a careful history, a complete strabismus evaluation involves careful measuring of the alignment in the diagnostic gaze positions and noting the eye muscle actions in the cardinal positions of gaze. The prism measurements and the eye movement gradings must be consistent with each other, so that an appropriate differential diagnosis can be developed. A good refraction is also a vital component of the work-up. This presentation comprises a selection of pearls and tips learned and applied over several decades in the author’s strabismus practice. These tips have helped improve diagnostic skills as well as treatment of both basic and advanced strabismus cases. These items will be discussed in 3 categories: diagnostic testing, non-surgical management, and surgical management. Some items are referenced in various sources, while others have not, to the presenter’s knowledge, been published before. At the end of each section, the specific pearl(s) for the audience will be noted as well as the application of that information. It is hoped that these tips will prove useful for novice as well as seasoned strabismus practitioners.
  • 蔡忠斌 Chong-Bin TsaiTaiwan Moderator Could Botulinum Toxin Be an Effective Primary Treatment for Infantile Esotropia?Introduction: To report the long-term success rate of botulinum toxin as the primary treatment for infantile esotropia. Methods: A single-center, retrospective review examined botulinum toxin use in children with esotropia onset before 12 months and presented by age 48 months. Success was defined as ocular alignment within 10 prism diopters (PD) of orthotropia. Results: A total of 35 children received botulinum toxin as primary treatment (1 injection: 63%; 2 injections: 17%; 3 injections: 14%; 4 injections: 6%). Of these, 20 (57%) had only botulinum toxin (BT group), while 15 (43%) had both botulinum toxin and surgery (BT+OP group). The mean deviation at initial presentation was 46.5 ± 13.8 PD in the BT group and 47.3 ± 11.3 PD in the BT+OP group. The mean age for initial botulinum toxin treatment was 1.8 ± 0.8 years for the BT group and 1.5 ± 0.8 years for the BT+OP group. The average follow-up time was 37.3 ± 22.6 months for the entire group. The success rate was 75% (15 of 20) for the BT group and 53% (8 of 15) for the BT+OP group, with no significant difference in success rates between the groups. Conclusions: Botulinum toxin demonstrated a notable long-term success rate as a primary treatment for infantile esotropia. These findings suggest botulinum toxin is an effective initial treatment option, with sustained results observed over an average follow-up of over three years.
    王安國 An-Guor WangTaiwan Moderator Upshooting Eye After TED IR Myectomy: How Do We Manage? Two TED patients received IR myectomy for hypotropoia. They developed upshooting eyes with severe limitation of infraduction postoperatively. We collaborated with ENT surgeon using endoscopic surgery with navigation system to identify the proximal stump of IR, and repair with non-absorbable suture. Both patients recovered their binocular vision after the operation.
  • Stephen KraftCanada Speaker Adult Strabismus Surgery: Do Adjustable Sutures Increase the Success of Surgery?Studies comparing strabismus surgical cases using adjustable sutures (AS) to non-adjustable procedures (NA) have focused on the rate of re-operations as well as the alignment results. The majority of the articles, encompassing hundreds of patients, show that AS improve success from both the reoperation rate and alignment aspects. However, systematic reviews point out that prospective controlled studies are lacking, and so conclusions cannot be drawn about the effectiveness of AS. This presentation will provide a brief review of the main articles in the literature comparing success rates with AS versus NA cases, as well as the five goals of an eye muscle operation. Following this introduction, the talk will illustrate the technique the author uses for his AS. Finally, the author will present three lines of evidence confirming the improved alignment success of using AS versus NA cases. This evidence derives from his over 40 years of experience and which is published in several articles from his centre. It is hoped that after this presentation, both novice and experienced strabismus surgeons will feel comfortable incorporating AS into their cases. They will also understand that the additional time and effort in using AS will be justified in improving the success rate of their surgery.Pearls and Tips from 43 Years in StrabismologyIn addition to a careful history, a complete strabismus evaluation involves careful measuring of the alignment in the diagnostic gaze positions and noting the eye muscle actions in the cardinal positions of gaze. The prism measurements and the eye movement gradings must be consistent with each other, so that an appropriate differential diagnosis can be developed. A good refraction is also a vital component of the work-up. This presentation comprises a selection of pearls and tips learned and applied over several decades in the author’s strabismus practice. These tips have helped improve diagnostic skills as well as treatment of both basic and advanced strabismus cases. These items will be discussed in 3 categories: diagnostic testing, non-surgical management, and surgical management. Some items are referenced in various sources, while others have not, to the presenter’s knowledge, been published before. At the end of each section, the specific pearl(s) for the audience will be noted as well as the application of that information. It is hoped that these tips will prove useful for novice as well as seasoned strabismus practitioners.
  • 莊怡群 Ann Yi-Chiun ChuangTaiwan Moderator Small-Optical-Zone Ortho-K in Myopia Control 小光心角膜塑型片於近視控制中的應用Orthokeratology (Ortho-K) represents the foundation of modern optical myopia control through the induction of peripheral myopic defocus. Subsequent optical interventions, including myopia-control spectacle and soft contact lenses, were developed based on the same principle. A newer advancement in this field is the small-optical-zone overnight Ortho-K design, exemplified by the myOK-pro lens. This approach preserves the advantages of conventional Ortho-K while enhancing myopia-control efficacy by reducing the central treatment zone to generate greater peripheral myopic defocus. Traditional Ortho-K tends to provide stronger control in higher prescriptions, whereas low-myopia patients often experience limited defocus and consequently weaker outcomes. For children who are unsuitable for or unwilling to wear spectacles or soft lenses, this presents a therapeutic gap. Small-optical-zone designs aim to address this need by improving defocus magnitude for low-myopia patients. However, simply reducing the optical zone in older designs may increase visual disturbances such as flare and halo. Modern small-optical-zone lenses seek to overcome these limitations, offering optimized visual quality alongside improved myopia-control performance.
  • 林慧茹 Hui-Ju LinTaiwan Speaker Advances in Artificial Intelligence Models and Algorithms in Amblyopia and Strabismus Review of Artificial Intelligence (AI) models that detect strabismus and amblyopia risk factors from smartphone photos, videos, and images, facilitating large-scale, accessible community screening. Discussion on how AI is personalizing amblyopia therapy, thereby maximizing efficacy and engagement. Critical appraisal of the requirements for clinical validation, regulatory approval, and the ethical integration of these AI tools into standard ophthalmic practice. AI is poised to fundamentally reshape the management of strabismus and amblyopia by introducing unprecedented levels of objectivity, accessibility, and personalization. the knowledge to understand, evaluate, and eventually integrate these powerful technologies into their practice to improve patient outcomes. AI screening and diagnosis to treatment optimization and monitoring.
  • 蔡紫薰 Tzu-Hsun TsaiTaiwan Speaker Facts and Myths: What We Need to Know About Atropine Eye DropsA study conducted in Taiwan during the 1990s demonstrated that atropine reduced myopia progression in a dose-dependent manner. Since that time, the clinical use of atropine in school-aged children has been widespread in Taiwan for more than two decades. Owing to this long history of high-concentration atropine prescriptions, Taiwan represents a distinctive setting in which to evaluate the long-term safety of atropine use. Using data from a large cohort within the NHIRD, we found that the incidence of ocular complications was higher among individuals with myopia compared with those without. However, among participants with myopia, the incidence of these complications did not differ between atropine users and nonusers, and higher cumulative doses of atropine were not associated with increased risk. The long-term efficacy of atropine eye drops for myopia control also merits further investigation. The LAMP clinical trial demonstrated that continuous treatment with 0.05% atropine effectively controlled myopia progression over five years. In contrast, the ATLAS from Singapore reported that topical atropine use during childhood was not associated with long-term ocular complications; however, its long-term efficacy in myopia control was less conclusive. Furthermore, recent randomized clinical trials have yielded inconsistent findings regarding the effectiveness of low-dose atropine, and regulatory approval by the U.S. FDA remains pending. Further research is therefore warranted to refine atropine treatment strategies, including the optimal timing of initiation, adjustment of concentration, duration of therapy, and methods and timing of discontinuation. Most importantly, future work should aim to clarify the ultimate clinical significance and long-term benefits of atropine therapy for myopia control. 接軌國際:IMI 近視前期定義與台灣經驗分享Pre-myopia is an emerging concept in myopia prevention, referring to children within a specific age range who exhibit refractive errors that, along with certain risk factors, place them at increased risk of developing myopia and who may benefit from early intervention. This presentation focuses on the international definitions of pre-myopia and utilizes public health survey data and clinical evidence from Taiwan to analyze the prevalence of pre-myopia and explore issues related to myopia development.
  • 彭智培 Calvin PangHong Kong, China Speaker Genomic investigations on the progression of childhood myopiaCalvin CP Pang彭智培 Department of ophthalmology and visual sciences, The Chinese University of Hong Kong, Hong Kong, China Myopia, the commonest ocular disorder in most populations estimated to affect a half of the world’s population in 2050, is prevalent and serious in East Asians with a steep rising trend in Caucasian and other Asian populations. More than 200 associated loci spreading all chromosomes are associated with myopia. While children of myopic parents across most populations are more prone to develop myopia, lifestyles in near work and outdoor time also cast strong influence. After onset of myopia, progression is different among children. In our cohorts of Chinese trio families, school children at different severities, and children receiving atropine, we conducted whole genome association studies (GWAS) and whole exome sequencing (WES) to investigate genetic loci in association with myopia progression based on quantitative traits, myopia progression over 3 years and lifestyle parameters. Based on our three stage GWAS of children myopia, there are associations of scleral equivalent and axial length with SNPs in MIR4275, LOC101928911, TENM3 and FAM135B. We calculated children’s genetic risk score (GRS) and found myopia severity increased with both near work and GRS levels, higher GRS showed a greater decrease in SE with the same amount of near work. More genomic information will be revealed as our data analysis continues.
701F